ViaDor-GLP1 agonist

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameViaDor-GLP1 agonist
Drug Alias NameGLP-1 agonist (TransPharma Medical)ViaDerm-GLP1 agonistGLP-1 agonist (TransPharma Medical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTranspharma Medical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranspharma Medical
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A